This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM

Guest: Geert Kersten CEO of CEL SCI Corp $CVM

Ticker: $CVM

Website: https://cel-sci.com/

Geert Kersten Biography

Geert Kersten has served in his current leadership role as Chief Executive Officer at CEL-SCI Corporation (NYSE American: CVM) since 1995 and has been with CEL-SCI since 1987. He has been involved in the pioneering field of cancer immunotherapy for over three decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry. Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how CEL-SCI's Multikine product could potentially change the way cancer is treated. Prior to joining CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital. Mr. Kersten received his Undergraduate Degree in Accounting and an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC.

Investors Can Learn More:

https://cel-sci.com/new-investor-information/